Phase 3 to be initiated
Amp Volatility Score
Catalyst Info & Data Links
TITLE: Viaskin Peanut for Peanut allergy (ages 1-3 yr olds) Phase 3 to be initiated
Clinical Trial (NCT03211247) Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age (EPITOPE)
WHAT IS THE NEXT CATALYST EVENT?
Phase 3 To be initiated
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
Updated by MV
EPITOPE, viaskin, peanut allergy, allergic, DBVT, DBV technology, allergies, children
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See What The Community Is Saying - Click To See Full Post